EXPLORE!

Europe's drug regulator reviews J&J COVID-19 vaccine over blood clots

  897 Views

eMediNexus    10 April 2021

Europe’s drug regulator has stated that it is reviewing rare blood clots reported in four individuals in the United States who were administered Johnson & Johnson’s COVID-19 vaccine.

Johnson & Johnson (J&J) said that it was aware of the rare reports of blood clots in the people who had been given its COVID-19 vaccine, and that it was working with regulators to evaluate the data and provide information. The company stated that there was no clear causal relationship at present between the rare blood clot events and the Janssen COVID-19 vaccine.

The European Medicines Agency is also reviewing how AstraZeneca COVID-19 vaccine is linked with rare cases of unusual blood clots and stated that it was looking at reports of capillary leak syndrome in individuals who received the AstraZeneca vaccine… (Reuters, April 9, 2021)

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.